Cargando…
Diacerein: A potential multi-target therapeutic drug for COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 19 (COVID-19), was declared pandemic by the World Health Organization in March 2020. SARS-CoV-2 binds its host cell receptor, angiotensin-converting enzyme 2 (ACE2), through the viral spike (S) protein. Th...
Autores principales: | de Oliveira, Pedro Gonçalves, Termini, Lara, Durigon, Edison Luiz, Lepique, Ana Paula, Sposito, Andrei C, Boccardo, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263256/ https://www.ncbi.nlm.nih.gov/pubmed/32534337 http://dx.doi.org/10.1016/j.mehy.2020.109920 |
Ejemplares similares
-
Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
por: Zaki, Basma Mostafa, et al.
Publicado: (2015) -
Diacerein Improves Left Ventricular Remodeling and Cardiac Function by Reducing the Inflammatory Response after Myocardial Infarction
por: Torina, Anali Galluce, et al.
Publicado: (2015) -
HPV-Mediated Resistance to TNF and TRAIL Is Characterized by Global Alterations in Apoptosis Regulatory Factors, Dysregulation of Death Receptors, and Induction of ROS/RNS
por: Cabeça, Tatiane Karen, et al.
Publicado: (2019) -
Oxidative stress: therapeutic approaches for cervical cancer treatment
por: Silva, Gabriela Ávila Fernandes, et al.
Publicado: (2018) -
Ion-pair compounds of diacerein for enhancing skin permeability in vitro: the compatibility–permeability relationship of counter ion and diacerein
por: Liang, Yan, et al.
Publicado: (2022)